2003, Number 2
<< Back Next >>
Gac Med Mex 2003; 139 (2)
Postoperatory Enterocutaneous Fistulas.
Martínez-Ordaz JL, Luque-de-León E, Suárez-Moreno RM, Blanco-Benavides R
Language: Spanish
References: 57
Page:
PDF size: 80.59 Kb.
ABSTRACT
Enterocutaneous fistulas of the digestive tract is a major catastrophe of surgical practice. In most cases, they represent serious complications of abdominal surgery. A total of 90% of cases develop of a surgical complication or injury. Despite progress in the management of fistulas, they were traditionally associated with high morbidity and mortality rates.
The three major complications of fistulas have been electrolyte disturbance, malnutrition and sepsis. Complications are strongly related to anatomic site of fistula, to biochemical and electrolyte content of discharge, output, and underlying pathology.
The ultimate objective in management of patients with enterocutaneous fistulas is fistula closure. In 1964, Chapman proposed management for fistulas in which a set of priorities in treatment was emphasized. Medical treatment is intended to cure (spontaneous closure) or to prepare patients for surgery. It was recognized that adequate nutritional support is an essential part of treatment of enterocutaneous fistulas. Control of sepsis is a priority because sepsis is the most common cause of death. Uncontrolled sepsis should be attacked as early as possible.
Although spontaneous closure has increased in most series, it is likely that the majority of patients will require an operation and this should be performed at the proper time.
REFERENCES
Halversen RC, Hogle HH, Richards RC. Gastric and small bowel fistulas. Am J Surg 1969; 118:968-972.
2. Nassos TP, Braash JW. External small bowel fistulas. Current treatment and results. Surg Clin North Am 1971; 51:687-692.
3. Hollender LF, Meyer C, Avet D, Zeyer B. Postoperative fistulas of the small intestine: Therapeutic Principles. Worid J Surg 1983;7:474-480.
4. Martineau P, Schwed JA, Denis R. ls octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?. Am J Surg 1996; 172:386-395.
5. Arenas-Márquez H, Anaya-Prado R, Hurtado H, et al. Consenso mexicano en el manejo integral de las fístulas del aparato digestivo. Cir Gen 2000;22:287-29.
6. Fischer JE. The pathophysiology of enterocutaneous fistulas. World J Surg 1983; 7:446-450.
7. Edmunds Jr LH, Williams GM, Welch CE. External fistulas arising from the gastrointestinal tract. Ann Surg 1960; 1 52:445-471.
8. Chapman R, Foran R, Dunphy JE. Management of intestinal Fistulas. Am J Surg 1964;108:157-164.
9. Aguirre A, Fischer JE, Welch CE. The role of surgery and hyperalimentation in therapy of gastrointestinal-cutaneous fistulae. Ann Surg 1 974;180:393-401.
Mclntyre PB, Ritchie JK, Hawley PR, Bartram CI, Lennard-Jones JE. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 1984; 71:293-296.
Rose D, Yarborough MF, Canizaro PC, Lowry SF. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obstet 1986; 163:345-350.
Prickett D, Montgomery R, Cheadie WG. External fistulas arising from the digestive tract. South Med J. 1991; 84:736-739.
Kuvshinoff BW, Brodish RJ, McFadden DW, Fischer JE. Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas. Ann Surg 1993; 217-.6l 5-623.
Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am 1996; 76:1027-1036.
Lévy E, Frileux P, Cugnenc PH, Honiger J, Ollivier JM, Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989; 76:676-679.
Sheldon GF, Gardiner BN, Way LW, Dunphy JE. Management of gastrointestinal fistulas. Surg Gynecol Obstet 1971; 133:385-389.
Mc Fayden Jr BV, Dudrick SJ, Ruberg RL. Management of gastrointestinal fistulas with parenteral hyperalimentation. Surgery 1973; 74:100-105.
Schein M. Postoperative small bowel leak. Br J Surg 1999; 86:979-980.
Schein M, Decker GAG. Postoperative external alimentary tract fistulas. Am J Surg 1991; 161:435-438.
Berry SM, Fischer JE. Enterocutaneous fistulas. Curr Prob Surg 1994; 31:483-566.
Sitges-Serra A, Jaurrieta E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982; 69:147-150.
Soeters PB, Ebeid AM, Fischer JE. Review of 404 patients with gastrointestinal fistulas. Ann Surg 1979; 190:1 89-202.
Rubelowsky J, Machiedo GW. Reoperative versus conservative management for gastrointestinal fistulas. Surg Clin North Am 1991;1 71:147-157.
Fazio VW, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg 1983-1 7:481-488.
Foster CE, Lefor AT. General treatment of gastrointestinal fistulas. Recognition, stabilization, and correction of fluid and electrolyte imbalances. Surg Clin North Am 1996, 76.-1037-1052.
Dudrick SJ, Maharaj AR, McKeivey AA. Artificial nutrition support in patients with gastrointestinal fistulas. World J Surg 1999; 23:570-576.
Lorenzo G, Beal JM. Management of external small bowel fistulas. Arch Surg 1969; 99:394-396.
Buechter KJ, Leonovicz D, Hastings PR, Fonts C. Enterocutaneous fistulas following laparotomy for trauma. Am Surg 1991; 57:354-358.
Reber HA, Roberts C, Way LW, Dunphy JE. Management of external gastrointestinal fistulas. Ann Surg 1978; 188:460-467.
Campos ACL, Andrade DF, Campos GMR, Matias JEF, Coelho JCU. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am Coll Surg 1999; 188:483-490.
Hill GL. Operative strategy in the treatment of enterocutaneous fistulas. World J Surg 1983; 7:495-501.
Makhdoom ZA, Komar MJ, Still CD. Nutrition and enterocutaneous fistulas. J Clin Gastroenterol 2000; 31:195-204.
Ruy-Díaz RJA, Athié AAJ, Correa MP, Flores VA, Pong TC. Manejo con nutrición parenteral total de las fístulas enterocutáneas complicadas. Cir Gen 1997; 19:11-19
Gianotti L, Braga M, Fortis C, et al. A prospective randomized clinical trial on perioperative feeding with an arginine, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. JPEN 1999; 23:314-320.
Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: Results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449.
Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27:2799-2805.
Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery. Arch Surg 1 999;1134:1309-1316.
Koretz RL. Immunonutrition? Gastroenterology 1993; 104:936-938.
Koretz RL. The impact of immunonutrition. Gastroenterology 1995;109:1713-1714.
Atkinson S, Bihari D. Immunonutrition; we are what we eat. Gastroenterology 1996; 110:1676,1678.
Bernstein LH. The impact of immunonutrition. Gastroenterology 1996;110:1677-1678.
Castañón GJA, Miranda RR, Arias E, Fuentes PE, Zarate A. El análogo de somatostatina SMS (201-995) como tratamiento adyuvante en pacientes con fístulas externas del aparato digestivo. Gac Med Mex 1992; 128:285-288.
Sancho JJ, di Costanzo J, Nubiola P, et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82:638-641.
Alvarez C, McFadden DW, Reber HA. Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg 2000; 24:533-537.
Wong SKH, Lam YH, Lau JYW, Lee DWH, Chan ACW, Chung SCS. Diagnostic and therapeutic fistuloscopy: an adjuvant management in postoperative fistulas and abscesses after upper gastrointestinal surgery. Endoscopy 2000; 32:311-313.
Nakagawa K, Momono S, Sasaki Y, Furusawa A, Ujiie K. Endoscopic examination of fistula. Endoscopy 1990; 22:208-210.
Williams NMA, Scott NA, Irving MH. Successful management of external duodenal fistula in a specialized unit. Am J Surg 1997; 173:240-241.
Rolandelli R, Rosiyn JJ. Surgical management and treatment of sepsis associated with gastrointestinal fistulas. Surg Clin North Am 1996; 76:1111-1122.
Marescaux JF, Aprahamian M, Mutter D, et al. Prevention of anastomosis leakage: an artificial connective tissue. Br J Surg 1991; 78:440-444
Marone G, Santoro LM, Torre V. Successful endoscopic treatment of GI-tract fistulas with a fast-hardening aminoacid solution. Endoscopy 1989; 21:47-49.
Billi P, Alberani A, Baroncini D, et al. Management of gastrointestinal fistulas with N-2-Butyl-cyanoacrylate. Endoscopy 1998; 30:569.
Hwang TL, Chen MF. Randomized trial of fibrin tissue glue for low output enterocutaneous fistula. Br J Surg 1996; 83:112.
Padillo FJ, Regueiro JC, Canis M, et al. Percutaneous management of a high output duodenal fistula after pancreas transplantation using occluding coiled embolus and fibrin sealant. Transplant Proc 1999; 31:1715-1716.
Shand A, Pendiebury J, Reading S, Papachrysostomou M, Ghosh S. Endoscopic fibrin sealant injection: a novel method of closing a refractory gastrocutaneous fistula. Gastrointest Endosc 1997; 46:357-358.
Cellier C, Landi B, Faye A, et al. Upper gastrointestinal tract fistulae: endoscopic obliteration with fibrin sealant. Gastrointest Endosc 1996; 44:731733.
Khairy GEA, Al-Saigh A, Trincano NS, Al-Smayer S, Al-Damegh S. Percutaneous obliteration of duodenal fistula. J R Coll Surg Edinb 2000; 45:342-344.
Kearney R, Payne W, Rosemurgy A. Extra-abdominal closure of enterocutaneous fistula. Am Surg 1997; 63:406-409.